Towards Healthcare Research & Consulting
Colorectal Cancer Diagnostics Market
Updated Date: 20 July 2026   |   Report Code: 6833

Colorectal Cancer Diagnostics Market Growth, Innovations, and Market Size Forecast 2035

According to Payal Rabde, who specializes in periodontal tissue regeneration, bone grafting, alveolar bone regeneration, and guided bone regeneration, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the colorectal cancer diagnostics market. The global colorectal cancer diagnostics market size was estimated at USD 18.7 billion in 2025 and is predicted to increase from USD 20.36 billion in 2026 to approximately USD 43.87 billion by 2035, expanding at a CAGR of 8.9% from 2026 to 2035. Her analysis highlights the increasing adoption of stem cell-based regenerative therapies, digital dentistry integrated with regenerative treatments, advanced bone graft substitutes, biomaterials-based dental grafts and scaffolds, and stem cell-based regenerative therapies. The research also examines the competitive strategies of key industry participants, including Exact Sciences, F. Hoffmann-La Roches Ltd, Guardant Health, Olympus Corporation, Epigenomics AG, and Mainz Biomed N.V., shaping the future by advancing stem cell-based dental regeneration, expanding tissue engineering and biomaterial innovation, supporting minimally invasive regenerative dental procedures, strengthening regenerative solutions for periodontal and bone repair, and driving AI-assisted treatment planning and precision regenerative care in the global colorectal cancer diagnostics market.

Last Updated : 20 July 2026 Category: Diagnostics Insight Code: 6833 Format: PDF / PPT / Excel

Content

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

  • Market Dynamics
  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 7: Segmental & Regional Analysis

  • Global Colorectal Cancer Diagnostics  Market Analysis, By Test Type
    • Market Size, Forecast & CAGR, By Test Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Colorectal Cancer Diagnostics  Market Analysis, By Technology
    • Market Size, Forecast & CAGR, By Test Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Colorectal Cancer Diagnostics  Market Analysis, By Application
    • Market Size, Forecast & CAGR, By Test Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Colorectal Cancer Diagnostics  Market Analysis, By End User
    • Market Size, Forecast & CAGR, By Test Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Colorectal Cancer Diagnostics  Market Analysis, By Region
    • Market Size, Forecast & CAGR, By Test Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Colorectal Cancer Diagnostics  Market Analysis
  • North America Colorectal Cancer Diagnostics  Market Analysis, By Test Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Colorectal Cancer Diagnostics  Market Analysis, By Technology, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Colorectal Cancer Diagnostics  Market Analysis, By Application, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Colorectal Cancer Diagnostics  Market Analysis, By End User, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Colorectal Cancer Diagnostics  Market Analysis, By Country, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
      • U.S. Colorectal Cancer Diagnostics  Market Analysis
    • U.S. Colorectal Cancer Diagnostics  Market Analysis, By Test Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. Colorectal Cancer Diagnostics  Market Analysis, By Technology, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. Colorectal Cancer Diagnostics  Market Analysis, By Application, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U.S. Colorectal Cancer Diagnostics  Market Analysis, By End User, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Similar Analysis will be given for each country and each region

  • Canada
  • Mexico
  • Rest of North America

Europe

  • Western Europe
  • Germany
  • Italy
  • France
  • Spain
  • UK
  • Netherlands
  • Switzerland
  • Nordic Countries
  • Rest of Western Europe
  • Eastern Europe
  • Austria
  • Russia & Belarus
  • Poland
  • Türkiye
  • Rest of Eastern Europe

Asia Pacific

  • China
  • Taiwan
  • India
  • Japan
  • Vietnam
  • Australia and New Zealand
  • ASEAN Countries
  • South Korea
  • Rest of APAC

South America

  • Brazil
  • Argentina
  • Rest of South America

Middle East and Africa (MEA)

  • GCC Countries
  • South Africa
  • Egypt
  • Rest of MEA

Chapter 6: Competitive Insights

  • Competitive Analysis
    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By Test Type
      • By Technology
      • By Application
      • By End User
    • Strategies of Key Players
    • Insight From the Horse’s Mouth
  • Company Profiles
    • Exact Sciences Corporation
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis
    • F. Hoffmann-La Roche Ltd (Roche Diagnostics) 
    • Quest Diagnostics Incorporated
    • Danaher Corporation
    • Guardant Health, Inc.
    • Abbott
    • Fujifilm Holdings Corporation
    • Epigenomics AG
    • Eiken Chemical Co., Ltd
    • Olympus Corporation

FAQ's

Answer : The colorectal cancer diagnostics market is valued at USD 20.36 billion in 2026 and is on track to reach USD 43.87 billion by 2035, witnessing a steady CAGR of 8.9% during the forecast span.

Answer : North America is currently leading the colorectal cancer diagnostics market by 38% due to the rigorous screening programs & favourable reimbursement policies

Answer : US FDA, EMA, NIH, CDC, MedlinePlus.gov, CMS, NCI, ClinicalTrials.gov, ICMR, ACS, WHO, PMC, etc.

Meet the Team

Payal Rabde is a Healthcare Market Research Analyst at Towards Healthcare Research & Consulting with 4+ years of experience in pharmaceuticals, biotechnology, medical devices, and life sciences.

Learn more about Payal Rabde

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar